학술논문

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Document Type
Article
Author
Pagano, LivioSalmanton-García, JonMarchesi, FrancescoBlennow, OlaGomes da Silva, MariaGlenthøj, Andreasvan Doesum, JaapBilgin, Yavuz M.López-García, AlbertoItri, FedericoNunes Rodrigues, RaquelWeinbergerová, BarboraFarina, FrancescaDragonetti, GiuliaBerg Venemyr, Carolinevan Praet, JensJaksic, OzrenValković, ToniFalces-Romero, IkerMartín-Pérez, SoniaJiménez, MoraimaDávila-Valls, JulioSchönlein, MartinAmmatuna, EmanueleMeers, StefDelia, MarioStojanoski, ZlateNordlander, AnnaLahmer, TobiasImre Pinczés, LászlóBuquicchio, CaterinaPiukovics, KláraOrmazabal-Vélez, IratiFracchiolla, NicolaSamarkos, MichailMéndez, Gustavo-AdolfoHernández-Rivas, José-ÁngelEspigado, IldefonsoCernan, MartinPetzer, VerenaLamure, Sylvaindi Blasi, RobertaMarques de Almedia, JoyceDargenio, MichelinaBiernat, Monika M.Sciumè, Mariaritade Ramón, Cristinade Jonge, NickBatinić, JosipAujayeb, AvinashMarchetti, MoniaFouquet, GuillemetteFernández, NoemíZambrotta, GiovanniSacchi, Maria VittoriaGuidetti, AnnaDemirkan, FatihPrezioso, LuciaRáčil, ZdeněkNucci, MarcioMladenović, MilošLiévin, RaphaëlHanáková, MichaelaGräfe, StefanieSili, UluhanMachado, MarinaCattaneo, ChiaraAdžić-Vukičević, TatjanaVerga, LuisaLabrador, JorgeRahimli, LamanBonanni, MatteoPassamonti, FrancescoPagliuca, AntonioCorradini, PaoloHoenigl, MartinKoehler, PhilippBusca, AlessandroCornely, Oliver A.Serrano, LauraRibera-Santa Susana, José-MaríaMeletiadis, JosephTsirigotis, PanagiotisCoppola, NicolaMikulska, MalgorzataErben, NurettinBesson, CarolineMerelli, MariaGonzález-López, Tomás-JoséLoureiro-Amigo, JorgeGarcía-Vidal, CarolinaKort, Elizabeth deCuccaro, AnnarosaZompi, SofiaReizine, FlorianFinizio, OlimpiaDuléry, RémyCalbacho, MariaAbu-Zeinah, GhaithMalak, SandraZdziarski, PrzemyslawVarrichio, GinaTragiannidis, AthanasiosPlantefeve, GaëtanDuarte, RafaelDanion, FrançoisTisi, Maria ChiaraSakellari, IoannaKarthaus, MeinholfGroh, AnaFung, MonicaEmarah, ZiadCoronel-Ayala, Omar-FranciscoAnn Chai, Louis YiBrehon, MathiasBonuomo, ValentinaWolf, DominikWittig, JanaVehreschild, MariaPapa, Mario VirgilioNeuhann, JuliaJiménez-Lorenzo, María-JosefaGrothe, JanGavriilaki, EleniGarcía-Sanz, RamónGarcía-Poutón, NicoleEl-Ashwah, Shaimaa SaberEggerer, MatthiasCordoba, RaulÇolak, Gökçe MelisArellano, Elena
Source
Blood; December 2022, Vol. 140 Issue: 26 p2773-2787, 15p
Subject
Language
ISSN
00064971; 15280020
Abstract
•Mortality rate in patients with hematologic malignancy with breakthrough COVID-19 is ∼9%, lower than in the prevaccination era.•Patients who received monoclonal antibodies, alone or combined with antivirals, showed a better clinical outcome.